Lyft Competing In Lock-step With Uber Technologies: Analysts Eye ‘Multiple Shots’ On Goal For Growth
Lyft's FY27 targets reveal anticipated growth, prompting mixed analyst reactions, with upgrades, downgrades, and price forecast adjustments.
What’s Going On With Rocket Lab Shares Today?
Rocket Lab shares rise as the company announces the launch window for its 50th Electron launch, deploying IoT satellites for Kinéis.
Skechers Stock Set For Growth As Footwear Trends Remain Solid: BofA Analyst
Bank of America analyst Christopher Nardone has upgraded Skechers USA to Buy, raising the price target from $71 to $87. Nardone cites an improving wholesale environment, solid footwear trends, and conservative 2H sales guidance.
Why Is China Yuchai International Stock Gaining Today?
China Yuchai International shares surge after announcing $40 million share repurchase plan and approval of equity incentive plans by its subsidiaries.
Jake Paul-Mike Tyson Boxing Match Set To Stream On Netflix With New Date
Jake Paul vs. Mike Tyson rescheduled for Nov. 15, streamed live on Netflix. Co-main event: Katie Taylor vs Amanda Serrano for undisputed title.
What’s Going On With Salesforce Stock Today?
Salesforce unveils Slack lists for task management, while announcing London AI center; stock up 17% over past year.
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Moderna has submitted an FDA application for its 2024-2025 Spikevax formula, targeting the prevalent SARS-CoV-2 variant JN.1.
Vertex To Present New Data Demonstrating Significant Benefits Of Treatment With TRIKAFTA At The ECFS 47th European Cystic Fibrosis Conference Held June 5-8, 2024
- Results from a randomized, placebo-controlled study of TRIKAFTA® in people with cystic fibrosis with rare, non-F508del CFTR mutations showed statistically significant and clinically meaningful improvements in the
Why Is Robotic Surgery-Focused Penny Stock Asensus Surgical Trading Higher On Friday?
KARL STORZ Endoscopy-America has agreed to acquire Asensus Surgical for $0.35 per share, representing a 67% premium. This acquisition will bolster KARL STORZ's robotic surgical market presence.
Over 10,000 Lawsuits In Novo Nordisk’s Ozempic Case Assigned to New Judge
Judge Karen Marston takes over the high-profile Ozempic litigation involving over 10,000 lawsuits. Here's the latest.